GlassScriptPhysician profile
Jake Hunter Kreck
NPI 1851638126
$3,899.90
in general payments reported to CMS, 2019-2025
16 companies · $1,837 in 2025
The $1,837 reported for 2025 was more than what 90% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,076 · 2024: $986 · 2025: $1,837.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,726 · Consulting Fee: $825 · Education: $349.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,725.70 |
| Consulting Fee | $825.00 |
| Education | $349.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $829.48 | 2025 | Cabtreo, Jublia |
| Abbvie INC. | $700.50 | 2023-2025 | |
| Regeneron Healthcare Solutions, INC. | $689.08 | 2023-2025 | Dupixent |
| Janssen Biotech, INC. | $443.36 | 2023-2025 | Tremfya |
| Incyte Corporation | $233.24 | 2023-2025 | Opzelura |
| Genzyme Corporation | $201.37 | 2023-2025 | |
| Novartis Pharmaceuticals Corporation | $150.77 | 2023-2024 | |
| Dermavant Sciences, INC. | $140.70 | 2024 | Vtama |
| Sun Pharmaceutical Industries INC. | $127.61 | 2023-2024 | Ilumya |
| Ucb, INC. | $125.18 | 2024-2025 | Bimzelx |
| Lilly USA, LLC | $91.76 | 2023-2025 | Taltz, Olumiant, Ebglyss |
| Sanofi-Aventis U.S. LLC | $85.00 | 2024 | |
| Arcutis Biotherapeutics, INC. | $25.33 | 2025 | Zoryve |
| Amgen INC. | $20.53 | 2025 | Otezla |
| Organon LLC | $20.46 | 2025 | Vtama |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $15.53 | 2024 | Sotyktu |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jake Kreck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.